PhaBuilder

PhaBuilder is a company with leading synthetic biotechnology, focusing on the transformation and engineering of halophilic microorganisms. PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge Next Generation Industrial Biotechnology(NGIB) to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the synthetic biology intelligent development plant in Beijing China-German Industrial Park and the 10 kt/annum plant in Yichang, Hubei Province. It also plans to build up 3-5 large-scale production bases throughout China within five years. At present, PhaBuilder has completed three rounds of financing, raising around 650 million RMB in total. The investors include Sequoia Capita...